fierce health semaglutide Hims & Hers stock falls 25% as FDA curtails compounded GLP-1s Weight Loss
Description
Xiao-Yun X, Zhao-Hui M, Ke C, Hong-Hui H, Yan-Hong X
(Retatrutide) 2 .16 GLP-1 GIP (GIPR) GLP-1R
Tirzepatide (GLP-1/GIP receptor agonist) has a slightly different mechanism and side effect profile, making it suitable for some patients who experience intolerance to semaglutide
Therefore, a tri-agonist was designed, incorporating residues from GLP-1, glucagon and GIP, as well as having a stabilising CEX
This isn't about restriction or perfection
